{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:37:02Z","timestamp":1767040622173,"version":"3.48.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019813","name":"Hualien Armed Forces General Hospital","doi-asserted-by":"publisher","award":["HAFGH_E_114014"],"award-info":[{"award-number":["HAFGH_E_114014"]}],"id":[{"id":"10.13039\/100019813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-111272"],"award-info":[{"award-number":["TSGH-E-111272"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Defense-Medical Affairs Bureau","award":["MND-MAB-C07-112028"],"award-info":[{"award-number":["MND-MAB-C07-112028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The association between benzodiazepine receptor agonist (BZRA) exposure and adverse perinatal outcomes remains inconclusive. This study aimed to assess the risks of adverse pregnancy and neonatal outcomes associated with maternal BZRA exposure across pregnancy trimesters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 170,144 maternal BZRA users and 1,098,172 nonusers were obtained from the Taiwan\u2019s National Health Insurance database. We used cross-sectional study design with inverse probability of treatment weighting (IPTW) to evaluate the association between maternal BZRA exposure during each trimester and adverse pregnancy outcomes. The pregnancy period was classified into 4 intervals: preconception, first trimester, second trimester, and third trimester. Logistic regression was performed to estimate odds ratios (ORs) and 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Maternal BZRA exposure was associated with an increased risk of stillbirth (IPTW-OR 1.19, 95% CI 1.14\u20131.25), preterm birth (IPTW-OR:1.11, 95% CI 1.09\u20131.13), low birth weight (IPTW-OR:1.05, 95% CI 1.03\u20131.07), Apgar score\u2009&lt;\u20097 (IPTW-OR:1.17, 95% CI 1.12\u20131.22), and cesarean delivery (IPTW-OR:1.15, 95% CI 1.14\u20131.17) compared with nonusers. By timing, preconception exposure was modestly associated with preterm birth and cesarean delivery, and first-trimester exposure showed similar associations. The associations were most pronounced in the second trimester, with significantly elevated risks of stillbirth (2.29, 95% CI 2.11\u20132.48), preterm birth (1.38, 95% CI 1.33\u20131.43), Apgar score\u2009&lt;\u20097 (2.05, 95% CI 1.92\u20132.20), low birth weight (1.35, 95% CI 1.29\u20131.40), small for gestational age (1.07, 95% CI 1.03\u20131.11), cesarean Sect.\u00a0(1.21, 95% CI 1.18\u20131.24), and overall congenital malformations (1.27, 95% CI 1.13\u20131.43).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study observed a small but statistical association between BZRA exposure and several adverse pregnancy outcomes, which extended from the pre-pregnancy period through all trimesters. Clinicians should carefully weigh the risks and benefits when treating women who are pregnant or planning pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-025-08549-1","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T01:57:23Z","timestamp":1764986243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of benzodiazepine receptor agonists in different pregnancy trimesters and risk of maternal and neonatal outcomes: a propensity weighted cohort study in Taiwan"],"prefix":"10.1186","volume":"25","author":[{"given":"Ruei-Siang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Yin","family":"To","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Lin","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ting","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Fa","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"8549_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2019.01.021","volume":"248","author":"MG Boekhorst","year":"2019","unstructured":"Boekhorst MG, Beerthuizen A, Endendijk JJ, Van Broekhoven KE, Van Baar A, Bergink V, Pop VJ. Different trajectories of depressive symptoms during pregnancy. J Affect Disord. 2019;248:139\u201346.","journal-title":"J Affect Disord"},{"issue":"4","key":"8549_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00737-018-0909-z","volume":"22","author":"HK Kjeldgaard","year":"2019","unstructured":"Kjeldgaard HK, Vikanes \u00c5, Benth J\u0160, Junge C, Garthus-Niegel S, Eberhard-Gran M. The association between the degree of nausea in pregnancy and subsequent posttraumatic stress. Arch Womens Ment Health. 2019;22(4):493\u2013501.","journal-title":"Arch Womens Ment Health"},{"issue":"3","key":"8549_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s10578-021-01138-1","volume":"53","author":"GG Urizar","year":"2022","unstructured":"Urizar GG, Mu\u00f1oz RF. Role of maternal depression on child development: a prospective analysis from pregnancy to early childhood. Child Psychiatry Hum Dev. 2022;53(3):502\u201314.","journal-title":"Child Psychiatry Hum Dev"},{"issue":"8","key":"8549_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/da.22756","volume":"35","author":"S Tuovinen","year":"2018","unstructured":"Tuovinen S, Lahti-Pulkkinen M, Girchenko P, Lipsanen J, Lahti J, Heinonen K, Reynolds RM, H\u00e4m\u00e4l\u00e4inen E, Kajantie E, Laivuori H. Maternal depressive symptoms during and after pregnancy and child developmental milestones. Depress Anxiety. 2018;35(8):732\u201341.","journal-title":"Depress Anxiety"},{"issue":"2","key":"8549_CR5","doi-asserted-by":"publisher","first-page":"e0263760","DOI":"10.1371\/journal.pone.0263760","volume":"17","author":"N Insan","year":"2022","unstructured":"Insan N, Weke A, Forrest S, Rankin J. Social determinants of antenatal depression and anxiety among women in South asia: a systematic review & meta-analysis. PLoS One. 2022;17(2):e0263760.","journal-title":"PLoS One"},{"issue":"2","key":"8549_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clp.2019.02.004","volume":"46","author":"ER Raffi","year":"2019","unstructured":"Raffi ER, Nonacs R, Cohen LS. Safety of psychotropic medications during pregnancy. Clin Perinatol. 2019;46(2):215\u201334.","journal-title":"Clin Perinatol"},{"issue":"6","key":"8549_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajog.2009.06.061","volume":"201","author":"R Calderon-Margalit","year":"2009","unstructured":"Calderon-Margalit R, Qiu C, Ornoy A, Siscovick DS, Williams MA. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol. 2009;201(6):579. e571-579. e578.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8549_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0028-3908(84)90064-9","volume":"23","author":"J Richards","year":"1984","unstructured":"Richards J, M\u00f6hler H. Benzodiazepine receptors. Neuropharmacology. 1984;23(2):233\u201342.","journal-title":"Neuropharmacology"},{"key":"8549_CR9","doi-asserted-by":"publisher","first-page":"102507","DOI":"10.1016\/j.eclinm.2024.102507","volume":"70","author":"J Brandt","year":"2024","unstructured":"Brandt J, Bressi J, L\u00ea ML, Neal D, Cadogan C, Witt-Doerring J, Witt-Doerring M, Wright S. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review. EClinicalMedicine. 2024;70:102507.","journal-title":"EClinicalMedicine"},{"issue":"9","key":"8549_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","volume":"28","author":"J Wick","year":"2013","unstructured":"Wick J. The history of benzodiazepines. Consultant Pharmacist\u00ae. 2013;28(9):538\u201348.","journal-title":"Consultant Pharmacist\u00ae"},{"key":"8549_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jad.2020.03.014","volume":"269","author":"B Bais","year":"2020","unstructured":"Bais B, Molenaar NM, Bijma HH, Hoogendijk WJ, Mulder CL, Luik AI, et al. Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: a systematic review and meta-analysis. J Affect Disord. 2020;269:18\u201327.","journal-title":"J Affect Disord"},{"key":"8549_CR12","doi-asserted-by":"crossref","unstructured":"Lin YH, Chen MH, Chang YC, Chen L, Hsiung CA, Wu SI: Prevalence of exposure to benzodiazepines among pregnant women in Taiwan: A nationwide longitudinal study. J Sleep Res. 2022;31(6):e13678.","DOI":"10.1111\/jsr.13678"},{"issue":"6","key":"8549_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00737-009-0100-7","volume":"12","author":"S Juric","year":"2009","unstructured":"Juric S, Newport DJ, Ritchie JC, Galanti M, Stowe ZN. Zolpidem (Ambien\u00ae) in pregnancy: placental passage and outcome. Arch Women Ment Health. 2009;12(6):441\u20136.","journal-title":"Arch Women Ment Health"},{"issue":"6","key":"8549_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/pcn.13216","volume":"75","author":"J Saito","year":"2021","unstructured":"Saito J, Ishii M, Mito A, Yakuwa N, Kawasaki H, Tachibana Y, et al. Etizolam levels in maternal serum, cord blood, and breast milk during pregnancy and lactation: a case report. Psychiatry Clin Neurosci. 2021;75(6):211\u20132.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"7","key":"8549_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1089\/bfm.2021.0013","volume":"16","author":"J Saito","year":"2021","unstructured":"Saito J, Ishii M, Miura Y, Yakuwa N, Kawasaki H, Suzuki T, et al. Brotizolam during pregnancy and lactation: brotizolam levels in maternal serum, cord blood, breast milk, and neonatal serum. Breastfeed Med. 2021;16(7):579\u201382.","journal-title":"Breastfeed Med"},{"key":"8549_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104647","volume":"137","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang T, Ekheden I, Chang Z, Hellner C, Hasselstr\u00f6m J, Jayaram-Lindstr\u00f6m N, D\u2019Onofrio BM, Larsson H, Mataix-Cols D. Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: A systematic review. Neurosci Biobehavioral Reviews. 2022;137: 104647.","journal-title":"Neurosci Biobehavioral Reviews."},{"key":"8549_CR17","unstructured":"Bleyl SB, Schoenwolf GC: What is the timeline of important events during pregnancy that may be disrupted by a teratogenic exposure? Teratology Primer. The Teratology Society; 2010. Available from: https:\/\/birthdefectsresearch.org\/primer\/PrimerPDF\/What-Is-the-Timeline-of-Important-Events-During-Pregnancy-That-May-Be-Disrupted-by-a-Teratogenic-Exposure.pdf"},{"issue":"3","key":"8549_CR18","doi-asserted-by":"publisher","first-page":"e1003945","DOI":"10.1371\/journal.pmed.1003945","volume":"19","author":"Y Noh","year":"2022","unstructured":"Noh Y, Lee H, Choi A, Kwon JS, Choe S-A, Chae J, et al. First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: a population-based cohort study in South Korea. PLoS Med. 2022;19(3):e1003945.","journal-title":"PLoS Med"},{"issue":"10","key":"8549_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/bdr2.1497","volume":"111","author":"SC Tinker","year":"2019","unstructured":"Tinker SC, Reefhuis J, Bitsko RH, Gilboa SM, Mitchell AA, Tran EL, Werler MM, Broussard CS, Study NBDP. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National birth defects prevention Study, 1997\u20132011. Birth Defects Res. 2019;111(10):613\u201320.","journal-title":"Birth Defects Res"},{"key":"8549_CR20","unstructured":"Schoenwolf GC, Bleyl SB, Brauer PR, Francis-West PH: Larsen\u2019s human embryology. 5th ed. Philadelphia (PA): Elsevier\/Churchill Livingstone (Elsevier Health Sciences); 2014."},{"issue":"1","key":"8549_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.beem.2007.07.010","volume":"22","author":"PE Mullis","year":"2008","unstructured":"Mullis PE, Tonella P. Regulation of fetal growth: consequences and impact of being born small. Best Pract Res Clin Endocrinol Metab. 2008;22(1):173\u201390.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"8549_CR22","doi-asserted-by":"crossref","unstructured":"Grigoriadis S, Alibrahim A, Mansfield JK, Sullovey A, Robinson GE. Hypnotic benzodiazepine receptor agonist exposure during pregnancy and the risk of congenital malformations and other adverse pregnancy outcomes: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica. 2022;146(4):312\u201324.","DOI":"10.1111\/acps.13441"},{"issue":"3","key":"8549_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajog.2005.08.038","volume":"194","author":"BT Bateman","year":"2006","unstructured":"Bateman BT, Simpson LL. Higher rate of stillbirth at the extremes of reproductive age: a large nationwide sample of deliveries in the United States. Am J Obstet Gynecol. 2006;194(3):840\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"8549_CR24","doi-asserted-by":"crossref","unstructured":"Alexander GR, Salihu HM: Perinatal outcomes of singleton and multiple births in the United States, 1995\u201398. In: Blickstein I, Keith LG, editors. Prenatal Assessment of Multiple Pregnancy. CRC Press; 2018. p. 33\u201340.","DOI":"10.4324\/9780429462023-7"},{"issue":"6","key":"8549_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ajog.2010.07.039","volume":"203","author":"Y Yogev","year":"2010","unstructured":"Yogev Y, Melamed N, Bardin R, Tenenbaum-Gavish K, Ben-Shitrit G, Ben-Haroush A. Pregnancy outcome at extremely advanced maternal age. Am J Obstet Gynecol. 2010;203(6):558. e551-558. e557.","journal-title":"Am J Obstet Gynecol"},{"issue":"6 Part 1 of 2","key":"8549_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/01.GME.0000123643.76105.27","volume":"11","author":"FJ Broekmans","year":"2004","unstructured":"Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause. 2004;11(6 Part 1 of 2):607\u201314.","journal-title":"Menopause"},{"issue":"25","key":"8549_CR27","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med"},{"key":"8549_CR28","doi-asserted-by":"crossref","unstructured":"Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. bmj\u00a0. 2019;367:l5657.","DOI":"10.1136\/bmj.l5657"},{"issue":"7","key":"8549_CR29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jfma.2023.11.009","volume":"123","author":"KM Lin","year":"2024","unstructured":"Lin KM, Yang YH, Lee CP, Chen KJ, Yang YH, Sheen JM, Chien SJ. Maternal and neonatal outcomes in women with congenital heart disease: A nationwide population-based study. J Formos Med Assoc. 2024;123(7):744\u201350.","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"8549_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/pds.1457","volume":"16","author":"BN Wikner","year":"2007","unstructured":"Wikner BN, Stiller CO, Bergman U, Asker C, K\u00e4ll\u00e9n B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16(11):1203\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"8549_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/clpt.2010.97","volume":"88","author":"LH Wang","year":"2010","unstructured":"Wang LH, Lin HC, Lin CC, Chen YH, Lin HC. Increased risk of adverse pregnancy outcomes in women receiving Zolpidem during pregnancy. Clin Pharmacol Ther. 2010;88(3):369\u201374.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"8549_CR32","first-page":"553","volume":"29","author":"O Bonnot","year":"2003","unstructured":"Bonnot O, Vollset S, Godet P, d\u2019Amato T, Dalery J, Robert E. In utero exposure to benzodiazepine. Is there a risk for anal Atresia with lorazepam? L\u2019encephale. 2003;29(6):553\u20139.","journal-title":"L\u2019encephale"},{"issue":"4","key":"8549_CR33","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.4088\/JCP.18r12412","volume":"80","author":"S Grigoriadis","year":"2019","unstructured":"Grigoriadis S, Graves L, Peer M, Mamisashvili L, Dennis C-L, Vigod SN, Steiner M, Brown C, Cheung A, Dawson H. Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis. J Clin Psychiatry. 2019;80(4):1845.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"8549_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","volume":"33","author":"E Enato","year":"2011","unstructured":"Enato E, Moretti M, Koren G. Motherisk rounds: the fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can. 2011;33(1):46\u20138.","journal-title":"J Obstet Gynaecol Can"},{"issue":"7162","key":"8549_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","volume":"317","author":"LR Dolovich","year":"1998","unstructured":"Dolovich LR, Addis A, Vaillancourt JR, Power JB, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ. 1998;317(7162):839\u201343.","journal-title":"BMJ"},{"issue":"2","key":"8549_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0006-8993(87)90065-5","volume":"403","author":"JM Catelli","year":"1987","unstructured":"Catelli JM, Giakas WJ, Sved AF. GABAergic mechanisms in nucleus tractus solitarius alter blood pressure and vasopressin release. Brain Res. 1987;403(2):279\u201389.","journal-title":"Brain Res"},{"issue":"1","key":"8549_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0304-3940(95)12262-1","volume":"203","author":"K Yagi","year":"1996","unstructured":"Yagi K, Onaka T. A benzodiazepine, chlordiazepoxide, blocks vasopressin and Oxytocin release after footshocks but not osmotic stimulus in the rat. Neurosci Lett. 1996;203(1):49\u201352.","journal-title":"Neurosci Lett"},{"key":"8549_CR38","doi-asserted-by":"publisher","first-page":"1490154","DOI":"10.3389\/fphys.2024.1490154","volume":"15","author":"GA Arenas","year":"2024","unstructured":"Arenas GA, Lorca RA. Effects of hypoxia on uteroplacental and fetoplacental vascular function during pregnancy. Front Physiol. 2024;15:1490154.","journal-title":"Front Physiol"},{"issue":"10","key":"8549_CR39","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1111\/aogs.14937","volume":"103","author":"T Ghi","year":"2024","unstructured":"Ghi T, Fieni S, Ramirez Zegarra R, Pereira S, Dall\u2019Asta A, Chandraharan E. Relative uteroplacental insufficiency of labor. Acta Obstet Gynecol Scand. 2024;103(10):1910\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"8549_CR40","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/ajh.2008.239","volume":"21","author":"M Sedeek","year":"2008","unstructured":"Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, Granger JP. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens. 2008;21(10):1152\u20136.","journal-title":"Am J Hypertens"},{"issue":"7","key":"8549_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/jama.1987.03390070077027","volume":"257","author":"JR Woods","year":"1987","unstructured":"Woods JR, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA. 1987;257(7):957\u201361.","journal-title":"JAMA"},{"issue":"8","key":"8549_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1471-0528.1977.tb12659.x","volume":"84","author":"J Gamble","year":"1977","unstructured":"Gamble J, Moore J, Lamki H, Howard P. A study of plasma diazepam levels in mother and infant. BJOG Int J Obstet Gynaecol. 1977;84(8):588\u201391.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"6","key":"8549_CR43","first-page":"809","volume":"12","author":"Z Leibovitz","year":"2022","unstructured":"Leibovitz Z, Lerman-Sagie T, Haddad L. Fetal brain development: regulating processes and related malformations. Life (Basel). 2022;12(6):809.","journal-title":"Life (Basel)."},{"issue":"4","key":"8549_CR44","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1750-3639.2002.tb00467.x","volume":"12","author":"JW Olney","year":"2002","unstructured":"Olney JW, Wozniak DF, Jevtovic-Todorovic V, Farber NB, Bittigau P, Ikonomidou C. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol. 2002;12(4):488\u201398.","journal-title":"Brain Pathol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08549-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08549-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08549-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:32:01Z","timestamp":1767040321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-025-08549-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8549"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08549-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"type":"electronic","value":"1471-2393"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Taiwan Tri-Services General Hospital (TSGHIRB C202105085). The requirement for informed consent was waived by the Institutional Review Board of Taiwan Tri-Services General Hospital because all data were anonymized and de-identified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1344"}}